1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) is sponsored by National Institutes of Health. Provides sustained support for informatics technologies in cancer research, including ongoing bioinformatics resources and tools.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | UC Irvine Chao Family Comprehensive Cancer Center Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high value informatics research resources to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities.
As a component of the NCI's Informatics Technology for Cancer Research ( ITCR ) Program, this FOA focuses on sustaining operations and improving the user experience and availability of existing, widely-adopted informatics tools and resources. This is in contrast to early-stage and advanced development efforts to generate these tools and resources that are supported by companion ITCR FOAs.
The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, the proposed sustainment plan must provide clear justification for why the research resource should be maintained and how it has benefited and will continue to benefit the cancer research field.
In addition, mechanisms for assessing and maximizing the value of the resource to researchers and supporting collaboration and deep engagement between the resource and the targeted research community should be described. Application Due Date : Jun 13, 2023 - 5:00:PM Application Due Date : Nov 17, 2023 - 5:00:PM National Institutes of Health (NIH)
According to the current listing, eligibility includes: Nonprofits, higher education institutions, and other eligible organizations per NIH guidelines. Confirm the full requirements in the official notice before applying.
Applications for Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) are due October 20, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) is funded by National Institutes of Health. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article